Grandfield & Dodd LLC Trims Stake in Danaher Co. (NYSE:DHR)

Grandfield & Dodd LLC lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 1.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,106 shares of the conglomerate’s stock after selling 250 shares during the quarter. Grandfield & Dodd LLC’s holdings in Danaher were worth $3,644,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of DHR. nVerses Capital LLC bought a new stake in Danaher during the second quarter valued at about $25,000. CarsonAllaria Wealth Management Ltd. purchased a new stake in Danaher in the 2nd quarter worth approximately $25,000. MidAtlantic Capital Management Inc. purchased a new stake in Danaher in the 3rd quarter worth approximately $40,000. MFA Wealth Advisors LLC bought a new stake in Danaher during the 2nd quarter worth approximately $51,000. Finally, Financial Connections Group Inc. purchased a new position in Danaher during the second quarter valued at approximately $51,000. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.3 %

Shares of NYSE DHR opened at $230.76 on Wednesday. Danaher Co. has a fifty-two week low of $207.63 and a fifty-two week high of $281.70. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company has a market cap of $166.67 billion, a price-to-earnings ratio of 44.04, a PEG ratio of 4.24 and a beta of 0.85. The business’s 50 day moving average price is $260.45 and its 200-day moving average price is $260.32.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the firm posted $2.02 earnings per share. On average, sell-side analysts expect that Danaher Co. will post 7.51 earnings per share for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.47%. Danaher’s dividend payout ratio is currently 20.61%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on DHR. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Monday. Bank of America boosted their price objective on Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a research note on Thursday, October 31st. Barclays dropped their price target on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 23rd. Finally, Robert W. Baird reduced their price target on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $287.16.

Insider Transactions at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares in the company, valued at approximately $1,130,374.44. The trade was a 18.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 10.90% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.